Literature DB >> 16651657

A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin.

Catherine A Andrews1, Amit C Vas, Brian Meier, Juan F Giménez-Abián, Laura A Díaz-Martínez, Julie Green, Stacy L Erickson, Kristyn E Vanderwaal, Wei-Shan Hsu, Duncan J Clarke.   

Abstract

Topoisomerase II (Topo II) performs topological modifications on double-stranded DNA molecules that are essential for chromosome condensation, resolution, and segregation. In mammals, G2 and metaphase cell cycle delays induced by Topo II poisons have been proposed to be the result of checkpoint activation in response to the catenation state of DNA. However, the apparent lack of such controls in model organisms has excluded genetic proof that Topo II checkpoints exist and are separable from the conventional DNA damage checkpoint controls. But here, we define a Topo II-dependent G2/M checkpoint in a genetically amenable eukaryote, budding yeast, and demonstrate that this checkpoint enhances cell survival. Conversely, a lack of the checkpoint results in aneuploidy. Neither DNA damage-responsive pathways nor Pds1/securin are needed for this checkpoint. Unusually, spindle assembly checkpoint components are required for the Topo II checkpoint, but checkpoint activation is not the result of failed chromosome biorientation or a lack of spindle tension. Thus, compromised Topo II function activates a yeast checkpoint system that operates by a novel mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651657      PMCID: PMC1472475          DOI: 10.1101/gad.1367206

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

Review 1.  Checkpoints controlling mitosis.

Authors:  D J Clarke; J F Giménez-Abián
Journal:  Bioessays       Date:  2000-04       Impact factor: 4.345

2.  Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

Authors:  K Tanabe; Y Ikegami; R Ishida; T Andoh
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 3.  The nucleoskeleton and the topology of replication.

Authors:  P R Cook
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

4.  Chromosome assembly in vitro: topoisomerase II is required for condensation.

Authors:  Y Adachi; M Luke; U K Laemmli
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

5.  A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

Authors:  C S Downes; D J Clarke; A M Mullinger; J F Giménez-Abián; A M Creighton; R T Johnson
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

6.  Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II.

Authors:  E R Wood; W C Earnshaw
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.

Authors:  L A Zwelling; J Mayes; M Hinds; D Chan; E Altschuler; B Carroll; E Parker; K Deisseroth; A Radcliffe; M Seligman
Journal:  Biochemistry       Date:  1991-04-23       Impact factor: 3.162

8.  Cell cycle control of higher-order chromatin assembly around naked DNA in vitro.

Authors:  T Hirano; T J Mitchison
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

9.  Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase.

Authors:  C E Shamu; A W Murray
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

10.  Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks.

Authors:  D J Clarke; R T Johnson; C S Downes
Journal:  J Cell Sci       Date:  1993-06       Impact factor: 5.285

View more
  24 in total

Review 1.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  DNA topoisomerase II is a determinant of the tensile properties of yeast centromeric chromatin and the tension checkpoint.

Authors:  Tariq H Warsi; Michelle S Navarro; Jeff Bachant
Journal:  Mol Biol Cell       Date:  2008-08-13       Impact factor: 4.138

3.  The NIMA kinase is required to execute stage-specific mitotic functions after initiation of mitosis.

Authors:  Meera Govindaraghavan; Alisha A Lad; Stephen A Osmani
Journal:  Eukaryot Cell       Date:  2013-11-01

4.  A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition.

Authors:  Olivier Cuvier; Slavica Stanojcic; Jean-Marc Lemaitre; Marcel Mechali
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

Review 5.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

6.  Persistent mechanical linkage between sister chromatids throughout anaphase.

Authors:  Benjamin D Harrison; Margaret L Hoang; Kerry Bloom
Journal:  Chromosoma       Date:  2009-07-15       Impact factor: 4.316

7.  Topoisomerase IIalpha controls the decatenation checkpoint.

Authors:  Kuntian Luo; Jian Yuan; Junjie Chen; Zhenkun Lou
Journal:  Nat Cell Biol       Date:  2008-12-21       Impact factor: 28.824

8.  Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation.

Authors:  Rodrigo Bermejo; Ylli Doksani; Thelma Capra; Yuki-Mori Katou; Hirokazu Tanaka; Katsuhiko Shirahige; Marco Foiani
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

Review 9.  Role of Aurora B and Haspin kinases in the metaphase Topoisomerase II checkpoint.

Authors:  M Johansson; Y Azuma; D J Clarke
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

10.  Topoisomerase II deficiency leads to a postreplicative structural shift in all Saccharomyces cerevisiae chromosomes.

Authors:  Jessel Ayra-Plasencia; Cristina Ramos-Pérez; Silvia Santana-Sosa; Oliver Quevedo; Sara Medina-Suárez; Emiliano Matos-Perdomo; Marcos Zamora-Dorta; Grant W Brown; Michael Lisby; Félix Machín
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.